Jianbing Wu
State Key Laboratory Of Natural Medicines, P.R. China
Nanjing, 211198, China
Nanjing, 211198, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Clinical Challenges in Echinococcosis Treatment and Frontiers in New Drug Development: Current Status and Future Outlook.
Journal: Current medicinal chemistry
Published: March 05, 2026
S-Nitrosation-Based Target Discovery and Drug Development: Toward a Nitric Oxide Drug 2.0 Paradigm.
Journal: Journal of medicinal chemistry
Published: February 01, 2026
Targeting RNA binding proteins with small-molecule inhibitors: Advances, challenges, and therapeutic opportunities.
Journal: Acta pharmaceutica Sinica. B
Published: May 19, 2025
Identification of Nitric Oxide Donating Dasatinib Derivatives with Intraocular Pressure Lowering and Senolytic Activities.
Journal: Journal of medicinal chemistry
Published: April 14, 2025
From S-nitrosation targets to drugs: A potential new paradigm in disease treatment.
Journal: Acta pharmaceutica Sinica. B
Published: March 06, 2025
A Fluorescent Probe for Imaging and Treating S-Nitrosation Stress in OGD/R Cells.
Journal: Antioxidants (Basel, Switzerland)
Published: January 14, 2025
Topical application of magnolol ameliorates psoriasis-like dermatitis by inhibiting NLRP3/Caspase-1 pathway and regulating tryptophan metabolism.
Journal: Bioorganic chemistry
Published: October 25, 2024
Advancements and applications in radiopharmaceutical therapy.
Journal: Chinese journal of natural medicines
Published: October 09, 2024
Construction of New MRI Contrast Agents for Spatiotemporal Visualization of Nitric Oxide in Ischemia/Reperfusion Organs.
Journal: Journal of medicinal chemistry
Published: October 04, 2024
Development of Nitric Oxide-Donating Netarsudil Derivatives as a Synergistic Therapy for Glaucoma with Reduced Ocular Irritation.
Journal: Journal of medicinal chemistry
Published: August 20, 2024
Identification of 6-Fluorine-Substituted Coumarin Analogues as POLRMT Inhibitors with High Potency and Safety for Treatment of Pancreatic Cancer.
Journal: Journal of medicinal chemistry
Published: July 25, 2024
Last Updated: 09/26/2026